Ethics approval and consent to participate
This trial was approved by the ethics committee of the Affiliated Hospital of Jiaxing University, China, on September 06, 2022 (2022-LY-164) before experiment was started and that has been conducted in accordance with the principles set forth in the Helsinki Declaration. Written informed consent was obtained from all participants or their guardians.